SCHEMBL9242571

SCHEMBL9242571

FC(F)(F)Oc1ccccc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.53
TRPA1 O75762 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
RXRG P48443 2/20 0.42
PPARG P37231 1/20 0.42
IDO1 P14902 2/20 0.42
SLC22A12 Q96S37 1/20 0.41
S1PR1 P21453 1/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27660142 0.85 HSD11B1 (0.62) HSD11B1TRPA1TRPM8TRPV1S1PR1
SCHEMBL4654446 0.84 RXRA (0.47) HSD11B1TRPA1RXRARXRBRXRG
SCHEMBL10979587 0.82 HSD11B1 (0.44) HSD11B1TRPA1TRPM8TRPV1IDO1
SCHEMBL1685381 0.82 LTA4H (0.46) HSD11B1RXRARXRBRXRGPPARG
SCHEMBL6371363 0.81 TDP1 (0.47) HSD11B1RXRARXRBRXRGALDH1A1
SCHEMBL28098554 0.81 HSD11B1 (0.42) HSD11B1TRPA1TRPM8TRPV1RXRA
SCHEMBL13020168 0.81 HSD11B1 (0.42) HSD11B1RXRARXRBRXRGPPARG
SCHEMBL9871232 0.81 ADRA2A (0.41) HSD11B1RXRARXRBRXRGPPARG
SCHEMBL10922032 0.81 PPARG (0.40) HSD11B1RXRARXRBRXRGPPARG
SCHEMBL10417860 0.81 MPL (0.43) HSD11B1TRPA1TRPM8TRPV1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109790200-A For treating the azasteroid of tuberculosis 纽约州立大学研究基金会 2019-05-21 CN claimed
CN-102895230-A Antituberculous composition comprising oxazole compounds OTSUKA PHARMA CO LTD 2013-01-30 CN disclosed
CN-101277740-B Antituberculous composition comprising azole compound OTSUKA PHARMA CO LTD 2012-12-05 CN disclosed
CN-101277740-A Antituberculous compositions comprising * azole compounds OTSUKA PHARMA CO LTD (JP) 2008-10-01 CN disclosed
EP-0481317-B1 Method for dechlorination and/or debromination of aromatic compounds containing fluorine with chlorine and/or bromine BAYER AG (DE) 1995-08-09 EP disclosed
US-5283378-A Process for the dechlorination and/or debromination of fluorine-and chlorine- and/or bromine-containing aromatic compounds BAYER AKTIENGESELLSCHAFT (DE) 1994-02-01 US disclosed
EP-0481317-A2 Method for dechlorination and/or debromination of aromatic compounds containing fluorine with chlorine and/or bromine BAYER AG (DE) 1992-04-22 EP disclosed
EP-0180818-A2 Benzoyl ureas and intermediates BAYER AG (DE) 1986-05-14 EP disclosed